Logo image of BOI.PA

BOIRON SA (BOI.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:BOI - FR0000061129 - Common Stock

30.65 EUR
+0.25 (+0.82%)
Last: 1/22/2026, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, BOI scores 5 out of 10 in our fundamental rating. BOI was compared to 54 industry peers in the Pharmaceuticals industry. BOI has an excellent financial health rating, but there are some minor concerns on its profitability. BOI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BOI had positive earnings in the past year.
  • In the past year BOI had a positive cash flow from operations.
  • BOI had positive earnings in each of the past 5 years.
  • In the past 5 years BOI always reported a positive cash flow from operatings.
BOI.PA Yearly Net Income VS EBIT VS OCF VS FCFBOI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • BOI's Return On Assets of 3.45% is on the low side compared to the rest of the industry. BOI is outperformed by 61.11% of its industry peers.
  • Looking at the Return On Equity, with a value of 5.25%, BOI is in line with its industry, outperforming 40.74% of the companies in the same industry.
  • With a Return On Invested Capital value of 4.43%, BOI perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
  • BOI had an Average Return On Invested Capital over the past 3 years of 5.61%. This is significantly below the industry average of 13.93%.
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROIC 4.43%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
BOI.PA Yearly ROA, ROE, ROICBOI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • BOI's Profit Margin of 3.84% is in line compared to the rest of the industry. BOI outperforms 40.74% of its industry peers.
  • BOI's Profit Margin has declined in the last couple of years.
  • The Operating Margin of BOI (5.26%) is worse than 61.11% of its industry peers.
  • BOI's Operating Margin has declined in the last couple of years.
  • BOI's Gross Margin of 73.71% is fine compared to the rest of the industry. BOI outperforms 66.67% of its industry peers.
  • BOI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
BOI.PA Yearly Profit, Operating, Gross MarginsBOI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BOI is destroying value.
  • BOI has about the same amout of shares outstanding than it did 1 year ago.
  • BOI has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BOI is higher compared to a year ago.
BOI.PA Yearly Shares OutstandingBOI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BOI.PA Yearly Total Debt VS Total AssetsBOI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BOI has an Altman-Z score of 3.79. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.79, BOI is in line with its industry, outperforming 53.70% of the companies in the same industry.
  • The Debt to FCF ratio of BOI is 0.49, which is an excellent value as it means it would take BOI, only 0.49 years of fcf income to pay off all of its debts.
  • BOI has a Debt to FCF ratio of 0.49. This is amongst the best in the industry. BOI outperforms 92.59% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that BOI is not too dependend on debt financing.
  • BOI has a better Debt to Equity ratio (0.04) than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Altman-Z 3.79
ROIC/WACC0.54
WACC8.13%
BOI.PA Yearly LT Debt VS Equity VS FCFBOI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • BOI has a Current Ratio of 2.39. This indicates that BOI is financially healthy and has no problem in meeting its short term obligations.
  • BOI has a Current ratio of 2.39. This is in the better half of the industry: BOI outperforms 75.93% of its industry peers.
  • BOI has a Quick Ratio of 1.46. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.46, BOI is doing good in the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.46
BOI.PA Yearly Current Assets VS Current LiabilitesBOI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • BOI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.09%.
  • BOI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.40% yearly.
  • BOI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.80%.
  • BOI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.63% yearly.
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%

3.2 Future

  • Based on estimates for the next years, BOI will show a small growth in Earnings Per Share. The EPS will grow by 2.73% on average per year.
  • BOI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.54% yearly.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BOI.PA Yearly Revenue VS EstimatesBOI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BOI.PA Yearly EPS VS EstimatesBOI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 27.37, which means the current valuation is very expensive for BOI.
  • BOI's Price/Earnings ratio is in line with the industry average.
  • BOI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.32.
  • The Price/Forward Earnings ratio is 13.25, which indicates a correct valuation of BOI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BOI indicates a somewhat cheap valuation: BOI is cheaper than 74.07% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.32. BOI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 27.37
Fwd PE 13.25
BOI.PA Price Earnings VS Forward Price EarningsBOI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BOI is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
  • BOI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BOI is cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.43
EV/EBITDA 6.67
BOI.PA Per share dataBOI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.95
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

  • BOI has a Yearly Dividend Yield of 3.97%.
  • BOI's Dividend Yield is rather good when compared to the industry average which is at 1.59. BOI pays more dividend than 88.89% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, BOI pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

  • The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
BOI.PA Yearly Dividends per shareBOI.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

  • 107.57% of the earnings are spent on dividend by BOI. This is not a sustainable payout ratio.
DP107.57%
EPS Next 2Y2.73%
EPS Next 3YN/A
BOI.PA Yearly Income VS Free CF VS DividendBOI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BOI.PA Dividend Payout.BOI.PA Dividend Payout, showing the Payout Ratio.BOI.PA Dividend Payout.PayoutRetained Earnings

BOIRON SA

EPA:BOI (1/22/2026, 7:00:00 PM)

30.65

+0.25 (+0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)N/A
Inst Owners5.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap537.91M
Revenue(TTM)504.86M
Net Income(TTM)19.37M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP107.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 27.37
Fwd PE 13.25
P/S 1.07
P/FCF 14.43
P/OCF 10.16
P/B 1.46
P/tB 2.15
EV/EBITDA 6.67
EPS(TTM)1.12
EY3.65%
EPS(NY)2.31
Fwd EY7.55%
FCF(TTM)2.12
FCFY6.93%
OCF(TTM)3.02
OCFY9.84%
SpS28.77
BVpS21.03
TBVpS14.24
PEG (NY)4.95
PEG (5Y)N/A
Graham Number23.02
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROCE 5.9%
ROIC 4.43%
ROICexc 5.25%
ROICexgc 7.65%
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
FCFM 7.39%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexgc growth 3Y-33.41%
ROICexgc growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Debt/EBITDA 0.2
Cap/Depr 35.13%
Cap/Sales 3.1%
Interest Coverage 30.02
Cash Conversion 74.49%
Profit Quality 192.52%
Current Ratio 2.39
Quick Ratio 1.46
Altman-Z 3.79
F-Score7
WACC8.13%
ROIC/WACC0.54
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-11.18%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.74%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y57.85%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%

BOIRON SA / BOI.PA FAQ

Can you provide the ChartMill fundamental rating for BOIRON SA?

ChartMill assigns a fundamental rating of 5 / 10 to BOI.PA.


What is the valuation status of BOIRON SA (BOI.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BOIRON SA (BOI.PA). This can be considered as Fairly Valued.


How profitable is BOIRON SA (BOI.PA) stock?

BOIRON SA (BOI.PA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BOI stock?

The Price/Earnings (PE) ratio for BOIRON SA (BOI.PA) is 27.37 and the Price/Book (PB) ratio is 1.46.


Is the dividend of BOIRON SA sustainable?

The dividend rating of BOIRON SA (BOI.PA) is 4 / 10 and the dividend payout ratio is 107.57%.